106P Efficacy and tolerability of capecitabine and mitomycin-C based concurrent radiotherapy in patients with anal canal cancer.

Saved in:
Bibliographic Details
Title: 106P Efficacy and tolerability of capecitabine and mitomycin-C based concurrent radiotherapy in patients with anal canal cancer.
Authors: Bhargava, P.G.1, Engineer, R.2, Ramaswamy, A.1, Srinivas, S. Sujay1, Shah, M.1, Agarwal, A.1, Saklani, A.3, Parulekar, M.1, Mandavkar, S.1, Ostwal, V.S.1
Source: Annals of Oncology. 2020 Supplement 6, Vol. 31, pS1283-S1283. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 152684639
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 106P Efficacy and tolerability of capecitabine and mitomycin-C based concurrent radiotherapy in patients with anal canal cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Bhargava%2C+P%2EG%2E%22">Bhargava, P.G.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Engineer%2C+R%2E%22">Engineer, R.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Ramaswamy%2C+A%2E%22">Ramaswamy, A.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Srinivas%2C+S%2E+Sujay%22">Srinivas, S. Sujay</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Shah%2C+M%2E%22">Shah, M.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Agarwal%2C+A%2E%22">Agarwal, A.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Saklani%2C+A%2E%22">Saklani, A.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Parulekar%2C+M%2E%22">Parulekar, M.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Mandavkar%2C+S%2E%22">Mandavkar, S.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Ostwal%2C+V%2ES%2E%22">Ostwal, V.S.</searchLink><relatesTo>1</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2020 Supplement 6, Vol. 31, pS1283-S1283. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=152684639
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2020.10.126
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: S1283
    Titles:
      – TitleFull: 106P Efficacy and tolerability of capecitabine and mitomycin-C based concurrent radiotherapy in patients with anal canal cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bhargava, P.G.
      – PersonEntity:
          Name:
            NameFull: Engineer, R.
      – PersonEntity:
          Name:
            NameFull: Ramaswamy, A.
      – PersonEntity:
          Name:
            NameFull: Srinivas, S. Sujay
      – PersonEntity:
          Name:
            NameFull: Shah, M.
      – PersonEntity:
          Name:
            NameFull: Agarwal, A.
      – PersonEntity:
          Name:
            NameFull: Saklani, A.
      – PersonEntity:
          Name:
            NameFull: Parulekar, M.
      – PersonEntity:
          Name:
            NameFull: Mandavkar, S.
      – PersonEntity:
          Name:
            NameFull: Ostwal, V.S.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 11
              Text: 2020 Supplement 6
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 31
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1